申请人:Takeda Pharmaceutical Company Limited
公开号:US20140066420A1
公开(公告)日:2014-03-06
The present invention relates to
wherein each symbol is as defined in the specification. The compound of the present invention has a superior RBP4-lowering action, and is useful as a medicament for the prophylaxis or treatment of disease and condition mediated by increased RBP4.
本发明涉及其中每个符号均如规范中定义的化合物。本发明的化合物具有卓越的RBP4降低作用,并可用作预防或治疗由增加的RBP4介导的疾病和病症的药物。